Nonpigmented dysplastic melanocytic nevi

Archives of Dermatology

Volumn 133, Issue 8, 1997, Pages 992-994

  Knoell, Keith A ^a   Hendrix Jr , John D ^a   Patterson, James W ^a   McHargue, Chauncey A ^a   Wilson, Barbara B ^a   Greer, Kenneth E ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DYSPLASTIC NEVUS; EPIDERMIS HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; MELANOCYTIC NEVUS; PAPULE; PRIORITY JOURNAL;

EID: 0030789282     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.133.8.992     Document Type: Article

References (29)

1. Clark WH, Reimer RR, Greene MH, Ainsworth AM, Mastrangelo MJ. Origin of familial melanomas from heritable melanocytic lesions. Arch Dermatol. 1978; 14:732-738.
2. Greene MH, Clark WH, Tucker MA, et al. Acquired precursors of cutaneous melanoma: the familial dysplastic nevus syndrome. N Engl J Med. 1985;312:91-97.
3. Rhodes AR, Harrist TJ, Day CL, Mihm MC Jr, Fitzpatrick TB, Sober AJ, Dysplastic nevi in histologic association with 234 primary cutaneous melanomas. J Am Acad Dermatol. 1983;9:563-574.
4. Duray PH, Ernstoff MS. Dysplastic nevus in histologic contiguity with acquired nonfamilial melanoma. Arch Dermatol. 1987;123:80-84.
5. Clark WH, Elder DE, Guerry D IV, Epstein MM, Greene MH, Van Horn M. A study of tumor progression: the precursor lesion of superficial spreading and nodular melanoma. Hum Pathol. 1984;15:1147-1165.
6. Halpern AC, DuPont G, Elder DE, et al. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. Arch Dermatol. 1991;127:995-999.
7. NIH Consensus Development Panel on Early Melanoma. Diagnosis and treatment of early melanoma. JAMA. 1992;268:1314-1319.
8. Albert LS, Rhodes AR, Sober AS. Dysplastic melanocytic nevi and cutaneous melanoma: markers for increased melanoma risk for affected persons and blood relatives. J Am Acad Dermatol. 1990;22:69-75.
9. Kang S, Barnhill RL, Mihm MC, Fitzpatrick TB, Sober AJ. Melanoma risk in individuals with clinically atypical nevi. Arch Dermatol. 1994;130:999-1001.
10. Tucker MA, Fraser MC, Goldstein AM, Elder DE, Guerry D IV, Organic SM. Risk of melanoma and other cancers in melanoma-prone families. J Invest Dermatol. 1993;100:350S-355S.
11. Rigel DS, Rivers JK, Kopf AW, et al. Dysplastic nevi: markers for increased risk for melanoma. Cancer. 1989;63:386-389.
12. Theirston A, Grin C, Kopf A. Prospective follow-up for malignant melanoma in patients with atypical mole (dysplastic nevus) syndrome. J Dermatol Surg Oncol. 1991;17:44-48.
13. Elder DE, Greene MH, Guerry D IV, Kraemer KH, Clark WH. The dysplastic nevus syndrome: our definition. Am J Dermatopathol. 1982;4:455-460.
14. Kelly J, Crutcher W, Sagebiel R. Clinical diagnosis of dysplastic nevi. J Am Acad Dermatol. 1986;14:1044-1052.
15. Barnhill RL, Roush GC, Duray PH. Correlation of histologic architectural and cytoplasmic features with nuclear atypia in atypical (dysplastic) nevomelanocytic nevi. Hum Pathol. 1990;21:51-58.
16. Rhodes AR, Mihm MC Jr, Weinstock MA. Dysplastic melanocytic nevi: a reproducible histologic definition emphasizing cellular morphology. Mod Pathol. 1989;2:306-319.
17. Grosshans E, Sengel D, Heid E. La lentiginose blanche. Ann Dermatol Venereol. 1994;121:7-10.
18. Cummings KI, Collel WI. Idiopathic guttate hypomelanosis. Arch Dermatol. 1966;93:184-186.
19. Whitehead WJ, Moyer DG, Vander DE. Idiopathic guttate hypomelanosis. Arch Dermatol. 1966;94:279-281.
20. Ploysangam T, Dee-Ananlap S, Suvanprakorn P. Treatment of idiopathic guttate hypomelanosis with liquid nitrogen: light and electron microscopic studies. J Am Acad Dermatol. 1990;23:681-684.
21. Falabella R, Escobar CE, Carrascal E, Arroyave JA. Leukoderma punctata. J Am Acad Dermatol. 1988;18:485-494.
22. Kraemer K, Greene MH, Tarone R, Elder DE, Clark WH Jr, Guerry D IV. Dysplastic naevi and cutaneous melanoma risk. Lancet. 1983;2:1076-1077.
23. Elder DE, Goldman LI, Goldman SC, Greene MH, Clark WH Jr. Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer. 1980;46:1787-1794.
24. Newton JA, Bataille V, Griffiths K, et al. How common is the atypical mole phenotype in apparently sporadic melanoma? J Am Acad Dermatol. 1993;29:989-995.
25. Kraemer KH. Dysplastic nevi as precursors to hereditary melanoma. J Dermatol Surg Oncol 1983;9:619-622.
26. Kraemer KH, Tucker M, Tarone R, Elder DE, Clark WH Jr. Risks of cutaneous melanoma in dysplastic nevus syndrome types A and B. N Engl J Med. 1986;315:1615-1616.
27. Tucker MA, Halpern A, Holly EA, et al. Clinically recognized dysplastic nevi: a central risk factor for cutaneous melanoma. JAMA. 1997;277:1439-1444.
28. Green MH, Clark WH Jr, Tucker MA, Kraemer KH, Elder DE, Fraser MC. High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med. 1985;120:458-465.
29. Nordlund JJ, Kirkwood J, Forget BM, et al. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res. 1985;45:1855-1861.